Answers are grounded in this paper and cite their sources.
Case-control study assesses lipid parameters in CKD patients correlating eGFR with cardiovascular risk.
Introduction Dyslipidemia is a significant risk factor for cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD). Therefore, it is essential to identify cardiovascular risk at the earliest. Cystatin C is a novel biomarker due to its high sensitivity relative to creatinine for estimating glomerular filtration rate (GFR). Aim This study aimed to assess the correlation between cystatin C- and creatinine-based eGFR (using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) equations) and lipid parameters (total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), very-low-density lipoprotein cholesterol (VLDL-C)) in adult CKD patients versus age- and sex-matched healthy controls. Materials and methods This case-control study was carried out at Dhiraj General Hospital, Piparia, Gujarat, India. A total of 100 participants were enrolled, including 50 CKD patients and 50 healthy controls. Serum creatinine, cystatin C, and lipid profile were measured. eGFR was calculated using MDRD (creatinine-based) and CKD-EPI (cystatin C-based) equations. Correlations between creatinine- and cystatin C-based eGFR with lipid parameters were assessed. Results CKD patients demonstrated significantly higher serum creatinine (11.64±5.86 mg/dl) and cystatin C (6.39±2.11 mg/dl) levels compared to controls. Patients with CKD had significantly elevated levels of serum TG and VLDL-C, whereas HDL-C was significantly lower compared to the controls (p<0.05). TC, LDL-C, TC/HDL ratio, and LDL/HDL ratio showed no statistically significant differences in the study groups (p>0.05). Correlation analysis revealed no significant association between cystatin C-based and creatinine-based eGFR with lipid parameters (p>0.05). However, cystatin C-based eGFR showed relatively stronger negative correlation with TC (r=-0.1603), LDL-C (r=-0.1913), and LDL/HDL ratio (r=-0.1855) compared with creatinine-based eGFR. Conclusion Correlations between eGFR and lipid parameters were weak and not statistically significant; however, cystatin C-based eGFR showed a relatively stronger, though non-significant, association with lipid parameters compared with creatinine-based eGFR. Larger studies are required to further explore these relationships.
No takes yet. Share an insight, caveat, or question.
Vasava et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: